218772-62-4Relevant articles and documents
Benzylamine derivatives and its application on the medicament
-
Paragraph 0164; 0166; 0167, (2017/08/25)
The invention provides novel benzylamine derivatives or stereoisomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites and pharmaceutically acceptable salts or pro-drugs thereof for treating Alzheimer diseases. The invention also provides a medicine composition containing a compound provided by the invention and a method for treating the Alzheimer diseases by using the compound or the medicine composition of the compound provided by the invention.
A new fluorescent "turn-on" chemodosimeter for cyanide based on dual reversible and irreversible deprotonation of NH and CH groups
Zhang, Chuanxiu,Liu, Chuanxiang,Li, Baiyun,Chen, Jinju,Zhang, Hua,Hu, Zhou,Yi, Fengping
, p. 1968 - 1973 (2015/03/18)
A new fluorescent "turn-on" cyanide chemodosimeter 5 was developed for the first time based on the irreversible deprotonation/oxidation of the CH group followed by the reversible deprotonation of the NH group, with high selectivity and dramatic red-shifted absorption (≈263 nm). The photoinduced electron transfer (PET) is prevented by the irreversible process, which results in coplanar geometry between indole and naphthalimide causing enhancement of fluorescence.
FSH RECEPTOR ANTAGONISTS
-
Page/Page column 31, (2013/04/10)
The invention relates to FSH receptor antagonist according to general formula (I) or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders